A novel selective ERK1/2 inhibitor, Laxiflorin B, targets EGFR mutation subtypes in non-small-cell lung cancer.
一种新型选择性 ERK1/2 抑制剂 Laxiflorin B，靶向非小细胞肺癌中的 EGFR 突变亚型
期刊:Acta Pharmacologica Sinica
影响因子:8.4
doi:10.1038/s41401-023-01164-w
Chiang Cheng-Yao, Zhang Min, Huang Junrong, Zeng Juan, Chen Chunlan, Pan Dongmei, Yang Heng, Zhang Tiantian, Yang Min, Han Qiangqiang, Wang Zou, Xiao Tian, Chen Yangchao, Zou Yongdong, Yin Feng, Li Zigang, Zhu Lizhi, Zheng Duo
